PatientsVille.com Logo

PatientsVille

Endoxan Side Effects

Common Endoxan Side Effects


The most commonly reported Endoxan side effects (click to view or check a box to report):

Pyrexia (145)
Febrile Neutropenia (124)
Neutropenia (94)
Pneumonia (90)
Pancytopenia (68)
Sepsis (66)
Dyspnoea (62)
Anaemia (57)
Diarrhoea (56)
Vomiting (55)
Nausea (49)
Interstitial Lung Disease (48)
Septic Shock (44)
Respiratory Failure (44)
Thrombocytopenia (44)
Pulmonary Embolism (43)
Death (43)
Headache (39)
Cardiac Failure (39)
Cough (38)

➢ More



If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

Endoxan Side Effects Reported to FDA

The following Endoxan reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.


The appearance of Endoxan on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.
No Therapeutic Response
This is a report of a 31-year-old female patient (weight: NA) from DE, suffering from the following symptoms/conditions: complication of pregnancy, who was treated with Endoxan 1g (dosage: NA, start time: NS), combined with: NA. and developed a serious reaction and side effect(s). The consumer presented with:
  • No Therapeutic Response
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Endoxan 1g treatment in female patients, resulting in no therapeutic response side effect.

Infected Skin Ulcer, Pancytopenia, Cytomegalovirus Infection
This report suggests a potential Endoxan Infected Skin Ulcer, Pancytopenia, Cytomegalovirus Infection side effect(s) that can have serious consequences. A 64-year-old female patient (weight: NA) from US was diagnosed with the following symptoms/conditions: microscopic polyangiitis and used Endoxan (dosage: NA) starting NS. Soon after starting Endoxan the patient began experiencing various side effects, including:
  • Infected Skin Ulcer
  • Pancytopenia
  • Cytomegalovirus Infection
Drugs used concurrently:
  • Prednisone
  • Prednisone
  • Rituximab
  • Azathioprine
Although Endoxan demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as infected skin ulcer, may still occur.

Failure To Thrive
This Failure To Thrive problem was reported by a health professional from JP. A 22-year-old male patient (weight: NA) was diagnosed with the following symptoms/conditions: NA. On NS this consumer started treatment with Endoxan (dosage: NA). The following drugs were being taken at the same time: NA. When commencing Endoxan, the patient experienced the following unwanted symptoms/side effects:
  • Failure To Thrive
Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as failure to thrive, may become evident only after a product is in use by the general population.

Exposure During Pregnancy
This is a report of a 29-year-old female patient (weight: NA) from DE. The patient developed the following symptoms/conditions: breast cancer and was treated with Endoxan 1g (dosage: NA) starting Feb 10, 2014. Concurrently used drugs: NA.Soon after that, the consumer experienced the following side effects:
  • Exposure During Pregnancy
This opens a possibility that Endoxan 1g treatment could cause the above reactions, including exposure during pregnancy, and some female subjects may be more susceptible.


Vasculitis
A 66-year-old male patient (weight: NA) from RS with the following symptoms/conditions: sjogren^s syndrome,systemic sclerosis started Endoxan 1 G treatment (dosage: NA) on NS. Soon after starting Endoxan 1 G treatment, the subject experienced various side effects, including:
  • Vasculitis
Concurrently used drugs: NA.The patient was hospitalized. This finding indicates that some male patients could be more vulnerable to Endoxan 1 G.

Febrile Bone Marrow Aplasia, Ileus Paralytic, Tendon Pain, Colitis
A 39-year-old male patient from FR (weight: NA) experienced symptoms, such as: burkitt^s lymphoma and was treated with Endoxan 2000 Mg, Lyophilisat Pour Solution Injectable(dosage: NA). The treatment was initiated on Jul 24, 2012. After that a consumer reported the following side effect(s):
  • Febrile Bone Marrow Aplasia
  • Ileus Paralytic
  • Tendon Pain
  • Colitis
Concurrently used drugs, which potentially could have contributed to side effect(s) or affected Endoxan 2000 Mg, Lyophilisat Pour Solution Injectable efficacy:
  • Vincristine Sulfate
  • Mabthera
  • Doxorubicine Hydrochloride
  • Dexamethasone
  • Aracytine
  • Truvada
  • Truvada
  • Isentress


Bronchial Carcinoma
In this report, Endoxan 1g was administered for the following condition: granuloma.A 63-year-old male consumer from DE (weight: NA) started Endoxan 1g treatment (dosage: NA) on NS.Sometime after starting the treatment, the patient complained of the following side effect(s):
  • Bronchial Carcinoma
A possible interaction with other drugs could have contributed to this reaction: NA.Establishing a causal relationship between a specific drug and consumer's side effects is complex, but it is possible that in this report Endoxan 1g treatment could be related to the listed above side effect(s).

Serositis, Glaucoma, Osteoporosis
This is a report of the following Endoxan 1g side effect(s):
  • Serositis
  • Glaucoma
  • Osteoporosis
A 14-year-old female patient from JP (weight: NA) presented with the following condition: systemic lupus erythematosus and received a treatment with Endoxan 1g (dosage: NA) starting: 201302.The following concurrently used drugs could have generated interactions:
  • Predonine
  • Azanin
  • Selbex
  • Bonoteo
  • Domperidone
  • Alfarol
  • Granisetron
  • Methylprednisolone
The patient was hospitalized.This report suggests that a Endoxan 1g treatment could be associated with the listed above side effect(s).

Breast Cancer Recurrent, Bone Neoplasm
This Endoxan report was submitted by a 64-year-old female consumer from PL (weight: NA). The patient was diagnosed with: breast cancer and Endoxan was administered (dosage: NA) starting: 1997. The consumer developed a set of symptoms:
  • Breast Cancer Recurrent
  • Bone Neoplasm
Other drugs used simultaneously:
  • Methotrexate
  • Fluorouracil
  • Bisoprolol
  • Vinpocetine
  • Sertraline
Those unexpected symptoms could be linked to a Endoxan treatment, however establishing a potential drug-safety problem requires a more detailed clinical analysis.

Gastrointestinal Obstruction
This is a report of a possible correlation between Endoxan use and the following symptoms/side effect(s):
  • Gastrointestinal Obstruction
which could contribute to an assessment of Endoxan risk profile.A 64-year-old female consumer from PL (weight: NA) was suffering from breast cancer recurrent and was treated with Endoxan (dosage: NA) starting 201302.Other concurrent medications:
  • Doxorubicin
  • Bisoprolol
  • Vinpocetine
  • Sertraline
The patient was hospitalized.

Pneumonia
A 63-year-old female patient from FR (weight: NA) presented with the following symptoms: NA and after a treatment with Endoxan 50 Mg, Comprim? Enrob? (dosage: NA) experienced the following side effect(s):
  • Pneumonia
The treatment was started on 201311. Endoxan 50 Mg, Comprim? Enrob? was used in combination with the following drugs: NA.The patient was hospitalized.This report could alert potential Endoxan 50 Mg, Comprim? Enrob? consumers.

Hypokalaemia, Pancytopenia, Vomiting, Diarrhoea
In this report, a 50-year-old female patient from FR (weight: NA) was affected by a possible Endoxan 2000 Mg, Lyophilisat Pour Solution Injectable side effect.The patient was diagnosed with b-cell lymphoma. After a treatment with Endoxan 2000 Mg, Lyophilisat Pour Solution Injectable (dosage: NA, start date: Dec 06, 2013), the patient experienced the following side effect(s):
  • Hypokalaemia
  • Pancytopenia
  • Vomiting
  • Diarrhoea
The following simultaneously used drugs could have led to this reaction: NA.The patient was hospitalized.The findings here stress that side effects should be taken into consideration when evaluating a Endoxan 2000 Mg, Lyophilisat Pour Solution Injectable treatment.

Diplopia
This is a report of a 15-year-old male patient from PL (weight: NA), who used Endoxan (dosage: NA) for a treatment of lymphoma. After starting a treatment on NS, the patient experienced the following side effect(s):
  • Diplopia
The following drugs could possibly have interacted with the Endoxan treatment NA.Taken together, these observations suggest that a Endoxan treatment could be related to side effect(s), such as Diplopia.

Kaposi^s Sarcoma, Sepsis
This kaposi^s sarcoma side effect was reported by a health professional from FR. A 69-year-old female patient (weight:NA) experienced the following symptoms/conditions: plasma cell myeloma. The patient was prescribed Endoxan 2000 Mg, Lyophilisat Pour Solution Injectable (dosage: NA), which was started on Mar 08, 2013. Concurrently used drugs: NA. When starting to take Endoxan 2000 Mg, Lyophilisat Pour Solution Injectable the consumer reported the following symptoms:
  • Kaposi^s Sarcoma
  • Sepsis
The patient was hospitalized. These side effects may potentially be related to Endoxan 2000 Mg, Lyophilisat Pour Solution Injectable.

Kaposi^s Sarcoma
This is a Endoxan 50 Mg, Comprim? Enrob? side effect report of a 63-year-old female patient (weight:NA) from FR, suffering from the following symptoms/conditions: amyloidosis, who was treated with Endoxan 50 Mg, Comprim? Enrob? (dosage:NA, start time: Aug 05, 2013), combined with:
  • Velcade
  • Dexamethasone
  • Januvia
  • Lipanthyl
  • Gaviscon
  • Bactrim
  • Phenoxymethylpenicillin
  • Zelitrex
, and developed a serious reaction and a kaposi^s sarcoma side effect. The patient presented with:
  • Kaposi^s Sarcoma
which developed after the beginning of treatment. The patient was hospitalized. This side effect report can indicate a possible existence of increased vulnerability to Endoxan 50 Mg, Comprim? Enrob? treatment in female patients suffering from amyloidosis, resulting in kaposi^s sarcoma.

Supraventricular Tachycardia, Tinnitus, Condition Aggravated
This report suggests a potential Endoxan 50 Mg, Comprim? Enrob? supraventricular tachycardia side effect(s) that can have serious consequences. A 58-year-old male patient from FR (weight:NA) was diagnosed with the following health condition(s): waldenstrom^s macroglobulinaemia and used Endoxan 50 Mg, Comprim? Enrob? (dosage: NA) starting Oct 28, 2013. Soon after starting Endoxan 50 Mg, Comprim? Enrob? the patient began experiencing various side effects, including:
  • Supraventricular Tachycardia
  • Tinnitus
  • Condition Aggravated
Drugs used concurrently:NA. Although Endoxan 50 Mg, Comprim? Enrob? demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as supraventricular tachycardia, may still occur.

Pneumonia, Non-hodgkin^s Lymphoma
This pneumonia problem was reported by a physician from IT. A 64-year-old female patient (weight: NA) was diagnosed with the following medical condition(s): non-hodgkin^s lymphoma.On Nov 21, 2013 a consumer started treatment with Endoxan Baxter (dosage: NA). The following drugs/medications were being taken at the same time:
  • Myocet
  • Mabthera
  • Deltacortene
  • Vincristina Solfato
When commencing Endoxan Baxter, the patient experienced the following unwanted symptoms /side effects:
  • Pneumonia
  • Non-hodgkin^s Lymphoma
The patient was hospitalized. Although all drugs are carefully tested before they are licensed for use, they carry potential side effect risks. Some side effects, such as pneumonia, may become evident only after a product is in use by the general population.

Diabetes Mellitus, Oral Candidiasis, Leukopenia, Deep Vein Thrombosis
This is a Endoxan Baxter side effect report of a 73-year-old male patient (weight: NA) from IT. The patient developed the following symptoms/conditions: antineutrophil cytoplasmic antibody positive,pulse abnormal and was treated with Endoxan Baxter (dosage: NA) starting NS. Concurrently used drugs:
  • Methylprednisolone
  • Prednisone
  • Prednisone
  • Rituximab
  • 5% Platelet Lysate
Soon after that, the consumer experienced the following of symptoms:
  • Diabetes Mellitus
  • Oral Candidiasis
  • Leukopenia
  • Deep Vein Thrombosis
This opens a possibility that Endoxan Baxter could cause diabetes mellitus and that some male patients may be more susceptible.

Progressive Multifocal Leukoencephalopathy, Jc Virus Infection
A 74-year-old female patient (weight: NA) from NL with the following symptoms: diffuse large b-cell lymphoma started Endoxan I.v., Poeder Voor Oplossing Voor Injectie 200, 500, 1000 Mg treatment (dosage: 6 Total Doses) on NS. Soon after starting Endoxan I.v., Poeder Voor Oplossing Voor Injectie 200, 500, 1000 Mg treatment, the consumer experienced several side effects, including:
  • Progressive Multifocal Leukoencephalopathy
  • Jc Virus Infection
. Concurrently used drugs:
  • Doxorubicin (6 Total Doses)
  • Vincristine (6 Total Doses)
  • Prednisolone (6 Total Doses)
  • Rituximab (6 Total Doses)
  • Rituximab (3 Cycles)
  • Granulocyte Colony-stimulating Factor
This finding indicates that some patients can be more vulnerable to developing Endoxan I.v., Poeder Voor Oplossing Voor Injectie 200, 500, 1000 Mg side effects, such as progressive multifocal leukoencephalopathy.

Haemolysis, Hepatic Enzyme Increased
This haemolysis side effect was reported by a physician from CH. A 60-year-old male patient (weight:NA) experienced the following symptoms/conditions: bone marrow conditioning regimen,prophylaxis.The patient was prescribed Endoxan 1 G (dosage: NA), which was started on Dec 01, 2013. Concurrently used drugs:
  • Uromitexan Multidose 100 Mg/1 Ml
  • Uromitexan Multidose 100 Mg/1 Ml
  • Uromitexan Multidose 100 Mg/1 Ml
  • Busulfan
  • Busulfan
  • Atg Fresenius
  • Atg Fresenius
  • Metotrexate
.When starting to take Endoxan 1 G the consumer reported symptoms, such as:
  • Haemolysis
  • Hepatic Enzyme Increased
These side effects may potentially be related to Endoxan 1 G. The patient was hospitalized.

Intestinal Obstruction
This is a report of a 65-year-old female patient (weight: NA) from JP, suffering from the following symptoms/conditions: scleroderma, who was treated with Endoxan 1g (dosage: NA, start time: 201311), combined with:
  • Predonine
and developed a serious reaction and side effect(s). The consumer presented with:
  • Intestinal Obstruction
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Endoxan 1g treatment in female patients, resulting in intestinal obstruction side effect.

Biliary Tract Disorder, Hepatic Encephalopathy, Pneumonia
This report suggests a potential Endoxan 2000 Mg, Lyophilisat Pour Solution Injectable Biliary Tract Disorder, Hepatic Encephalopathy, Pneumonia side effect(s) that can have serious consequences. A 57-year-old male patient (weight: NA) from FR was diagnosed with the following symptoms/conditions: vasculitis and used Endoxan 2000 Mg, Lyophilisat Pour Solution Injectable (dosage: 400 Mg/m2) starting 201306. Soon after starting Endoxan 2000 Mg, Lyophilisat Pour Solution Injectable the patient began experiencing various side effects, including:
  • Biliary Tract Disorder
  • Hepatic Encephalopathy
  • Pneumonia
Drugs used concurrently:
  • Solupred
  • Solupred
  • Fortum
  • Ciflox
Although Endoxan 2000 Mg, Lyophilisat Pour Solution Injectable demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as biliary tract disorder, may still occur.

Aortic Valve Incompetence
This Aortic Valve Incompetence problem was reported by a health professional from TR. A 19-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: takayasu^s arteritis. On NS this consumer started treatment with Endoxan 1g. Iv (dosage: NA). The following drugs were being taken at the same time:
  • Prednisolone
  • Dipyridamole
When commencing Endoxan 1g. Iv, the patient experienced the following unwanted symptoms/side effects:
  • Aortic Valve Incompetence
Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as aortic valve incompetence, may become evident only after a product is in use by the general population.

Campylobacter Sepsis, Leukopenia, C-reactive Protein Increased, Pulmonary Embolism
This is a report of a 44-year-old male patient (weight: NA) from PL. The patient developed the following symptoms/conditions: lymphoma and was treated with Endoxan (dosage: NA) starting NS. Concurrently used drugs:
  • Rituximab
  • Doxorubicin
  • Vincristine
  • Prednisone
Soon after that, the consumer experienced the following side effects:
  • Campylobacter Sepsis
  • Leukopenia
  • C-reactive Protein Increased
  • Pulmonary Embolism
The patient was hospitalized. This opens a possibility that Endoxan treatment could cause the above reactions, including campylobacter sepsis, and some male subjects may be more susceptible.

Retinal Haemorrhage, Hypoaesthesia
A 48-year-old female patient (weight: NA) from FR with the following symptoms/conditions: breast cancer started Endoxan 2000 Mg, Lyophilisat Pour Solution Injectable treatment (dosage: NA) on 201302. Soon after starting Endoxan 2000 Mg, Lyophilisat Pour Solution Injectable treatment, the subject experienced various side effects, including:
  • Retinal Haemorrhage
  • Hypoaesthesia
Concurrently used drugs:
  • Xgeva
This finding indicates that some female patients could be more vulnerable to Endoxan 2000 Mg, Lyophilisat Pour Solution Injectable.

1 of 76 



Top 10 Endoxan Side Effects for Women

Women Side EffectsReports
Pyrexia 75
Febrile Neutropenia 72
Neutropenia 52
Vomiting 46
Dyspnoea 45
Pancytopenia 43
Nausea 38
Pneumonia 38
Diarrhoea 37
Sepsis 33

Top 10 Endoxan Side Effects for Men

Men Side EffectsReports
Pyrexia 70
Febrile Neutropenia 51
Pneumonia 51
Neutropenia 42
Sepsis 31
Interstitial Lung Disease 30
Respiratory Failure 29
Death 27
Pancytopenia 24
Anaemia 22

Keep Track of Side Effects

Note Your Observations

It is really important to keep of your symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

Why Your Notes are Important

Your notes could be helpful in several ways:

  • You can use them to remind you of details that may alert your health care professional(s) to a problem
  • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

  • Log Form

    You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

    Medicine Name and Dosage:
    Side Effects Scale Date & Time Other Medicine(s) or Treatment(s)
    Scale: 1 = very mild to 10 = very bad

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


    Discuss Endoxan Side Effects

    Did You Have a Endoxan Side Effect?

    Yes, Severe
    Yes, Moderate
    Yes, Minor
    No

    How Effective is Endoxan for You?

    Exceeded Expectations
    Effective
    Somewhat Effective
    Not Effective

    Endoxan Safety Alerts, Active Ingredients, Usage Information

    More About Endoxan

    Side Effects reported to FDA: 1890

    Endoxan safety alerts: No

    Reported deaths: 165

    Reported hospitalizations: 448

    Latest Endoxan clinical trials